Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
523 studies found for:    schizophrenia OR dementia praecox OR psychotic disorders OR schizophrenia disorders OR schizophreniform disorder OR schizoaffective disorder OR catalepsy OR schizoid personality disorder OR schizotypical personality disorder | Open Studies | NIH
Show Display Options
Rank Status Study
1 Recruiting Dopamine Function and Reward Processing In Schizophrenia
Condition: Schizophrenia
Intervention:
2 Recruiting Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
Conditions: Schizoaffective Disorder;   Schizophrenia
Intervention:
3 Recruiting Genetic Study of Schizophrenia
Conditions: Psychotic Disorder;   Schizoaffective Disorder;   Schizophrenia
Intervention:
4 Recruiting Inpatient Evaluation of Adults With Schizophrenia
Conditions: Psychotic Disorder;   Schizophrenia;   Schizoaffective;   Paranoia;   Psychosis
Intervention:
5 Recruiting Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia
Conditions: Psychosis;   Schizophrenia;   Genetic Structure;   Childhood Onset Psychotic Disorders;   Schizoaffective Disorder
Intervention:
6 Recruiting Studies of Frontal Lobe Brain Functioning in Schizophrenia
Conditions: Healthy;   Schizophrenia
Intervention:
7 Recruiting Database Registry to Examine Brain Connections and Brain Function in Mental Disorders and Neural Network Biomarkers for Relational Memory and Psychosis in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Intervention:
8 Recruiting Brain Circuits in Schizophrenia and Smoking
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
Intervention:
9 Recruiting Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Behavioral: Cognitive remediation training;   Drug: Nicotine polacrilex lozenge
10 Recruiting Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode
Conditions: Schizophrenia;   Schizophreniform Disorder;   Schizoaffective Disorder
Interventions: Behavioral: Case management and supportive psychotherapy;   Behavioral: Family psychoeducation;   Behavioral: Cognitive training;   Behavioral: Aerobic exercise
11 Recruiting Clinical Trial of AVL-3288 in Schizophrenia Patients
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: AVL-3288;   Drug: Placebo
12 Recruiting Neuronal Effects of Exercise in Schizophrenia
Condition: Schizophrenia
Interventions: Behavioral: Exercise;   Behavioral: Diet
13 Not yet recruiting Minocycline and Tobacco Craving in Smokers With Schizophrenia
Conditions: Schizophrenia;   Tobacco Use
Interventions: Drug: Minocycline;   Other: Placebo
14 Recruiting Personalized and Scalable Cognitive Remediation Approaches
Conditions: Schizophrenia;   Schizoaffective Disorder
Intervention: Behavioral: Cognitive remediation
15 Recruiting Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
Intervention:
16 Recruiting Improving Negative Symptoms of Psychosis In Real-world Environments
Condition: Schizophrenia
Interventions: Behavioral: CBSST-CCT;   Behavioral: Goal focused supportive contact
17 Recruiting Randomized Controlled Trial (RCT) of a Motivational Decision Support System
Condition: Schizophrenia
Interventions: Behavioral: Web-based motivational decision support system;   Behavioral: NCI Education
18 Recruiting STimulation to Improve Auditory haLLucinations
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Device: tACS (alpha);   Device: tDCS
19 Recruiting PET Scanning in Parkinson s Disease
Condition: Parkinson's Disease
Intervention:
20 Recruiting Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects
Condition: Schizophrenia
Interventions: Device: AVL-3288;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.